BriaCell Secures New Zealand Patent, Boosting Cancer Immunotherapy Prospects
2025-07-30
The Manila Times
Auckland, New Zealand – BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT), a pioneering clinical-stage biotechnology company, has received a significant boost to its cancer immunotherapy development program with the granting of New ...Read more
